⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BLTE News
Belite Bio, Inc American Depositary Shares
Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
globenewswire.com
BLTE
Belite Bio to Participate in Four Upcoming Investor Conferences
globenewswire.com
BLTE
Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th
globenewswire.com
BLTE
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
globenewswire.com
BLTE
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
globenewswire.com
BLTE
Belite Bio to Participate in the Leerink Global Healthcare Conference
globenewswire.com
BLTE
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
globenewswire.com
BLTE
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
BLTE
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
globenewswire.com
BLTE
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
globenewswire.com
BLTE